Latest News about GILD
Recent news which mentions GILD
From Benzinga
What's Next For NRx Pharma As FDA Denies Breakthrough Therapy Tag For COVID-19 Therapy
June 13, 2022
From Benzinga
ASCO 2022: Surprising News in Cancer Research
June 10, 2022
From Motley Fool
7 Great ETFs to Buy Now for Momentum in Q2
June 10, 2022
From InvestorPlace
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
From Benzinga
7 Oversold Stocks to Buy Right Now
June 08, 2022
From InvestorPlace
COVID patients with weak immune systems should get priority care to avoid new variants emerging, experts say
June 07, 2022
From MarketWatch
Heart conditions and gender may increase the risk for long COVID, according to 23andMe
June 01, 2022
From MarketWatch
7 Safe Dividend Stocks With High Yields to Buy Now
May 31, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Tickers
GILD
From Motley Fool
Pfizer: The Treasure of Albert Bourla
May 04, 2022
From InvestorPlace
Gilead Sciences (GILD) Q1 2022 Earnings Call Transcript
April 29, 2022
Tickers
GILD
From Motley Fool
Gilead Sciences Q1 Results Surpass Street Expectation, FY22 Outlook Midpoint Trails Consensus
April 28, 2022
Tickers
GILD
From Benzinga
From Benzinga
Is the S&P 500 All You Need to Retire a Millionaire?
April 28, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.